Wolverine Asset Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,155
Closed -$418K 2651
2022
Q2
$418K Buy
41,155
+10,223
+33% +$103K ﹤0.01% 1034
2022
Q1
$311K Sell
30,932
-2,911
-9% -$29.2K ﹤0.01% 1087
2021
Q4
$338K Buy
33,843
+2,437
+8% +$24.3K ﹤0.01% 1118
2021
Q3
$312K Sell
31,406
-5,568
-15% -$55K ﹤0.01% 1088
2021
Q2
$366K Buy
36,974
+7,647
+26% +$75.7K ﹤0.01% 1022
2021
Q1
$288K Buy
+29,327
New +$293K ﹤0.01% 1107

Other funds holding APGN

Wolverine Asset Management's APGN Position: Q3 2022 in Review

Wolverine Asset Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 41,155 shares — an estimated $418K sold.

Wolverine Asset Management first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $418K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Wolverine Asset Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 41,155 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $418K.
  • Wolverine Asset Management first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Wolverine Asset Management's Apexigen, Inc. Common Stock position peaked at $418K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.